𝔖 Bobbio Scriptorium
✦   LIBER   ✦

2140 POSTER A comparison of lapatinib plus capecitabine versus capecitabine for quality-adjusted survival in metastatic breast cancer (MBC): A QTWiST analysis

✍ Scribed by B. Sherrill; A. Allshouse; M.M. Amonkar; M.D. Walker; S.H. Stein

Book ID
118625744
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
60 KB
Volume
5
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

PCN9 VALIDITY OF PROPORTIONAL HAZARDS (P
PCN9 VALIDITY OF PROPORTIONAL HAZARDS (PH) WEIBULL MODELS FOR ANALYZING PROGRESSION FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN PATIENTS WITH TRASTUZUMAB (TZ)-REFRACTORY ERBB2+ (HER2+) METASTATIC BREAST CANCER (MBC) RECEIVING LAPATINIB PLUS CAPECITABINE (L+C) VERSUS CAPECITABINE ONLY (C-ONLY)
✍ O Sofrygin; T Delea; P Tappenden; J Karnon; MM Amonkar; M Walker πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 69 KB